Related Experiment Video
Updated: May 31, 2026

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA
Bryce L Sopher1, Paula D Ladd, Victor V Pineda
1Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.
Abstract:
Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder caused by CAG/polyglutamine repeat expansions in the ataxin-7 gene. Ataxin-7 is a component of two different transcription coactivator complexes, and recent work indicates that disease protein normal function is altered in polyglutamine neurodegeneration. Given this, we studied how ataxin-7 gene expression is regulated. The ataxin-7 repeat and translation start site are flanked by binding sites for CTCF, a highly conserved multifunctional transcription regulator. When we analyzed this region, we discovered an adjacent alternative promoter and a convergently transcribed antisense noncoding RNA, SCAANT1. To understand how CTCF regulates ataxin-7 gene expression, we introduced ataxin-7 mini-genes into mice, and found that CTCF is required for SCAANT1 expression. Loss of SCAANT1 derepressed ataxin-7 sense transcription in a cis-dependent fashion and was accompanied by chromatin remodeling. Discovery of this pathway underscores the importance of altered epigenetic regulation for disease pathology at repeat loci exhibiting bidirectional transcription.
Insights
Spinocerebellar ataxia type 7 (SCA7) involves altered ataxin-7 gene expression. CTCF regulates a noncoding RNA (SCAANT1) that represses ataxin-7 transcription, with its loss causing disease-associated epigenetic changes.
Area of Science:
- Neurogenetics
- Molecular Biology
- Epigenetics
Background:
- Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder linked to CAG/polyglutamine expansions in the ataxin-7 gene.
- Ataxin-7 protein is crucial for transcription coactivator complexes, and its function is impaired in polyglutamine diseases.
Purpose of the Study:
- To investigate the regulatory mechanisms of ataxin-7 gene expression.
- To understand the role of CTCF and a novel noncoding RNA in SCA7 pathogenesis.
Main Methods:
- Analysis of the ataxin-7 gene locus, including flanking CTCF binding sites and an alternative promoter.
- Introduction of ataxin-7 mini-genes into mouse models.
- Assessment of CTCF's role in SCAANT1 expression and its impact on ataxin-7 transcription and chromatin structure.
Main Results:
- Discovery of a convergently transcribed antisense noncoding RNA, SCAANT1, adjacent to the ataxin-7 gene.
- CTCF is essential for SCAANT1 expression.
- Loss of SCAANT1 leads to derepression of ataxin-7 sense transcription and associated chromatin remodeling in cis.
Conclusions:
- CTCF-mediated regulation of SCAANT1 is a critical pathway influencing ataxin-7 gene expression.
- Altered epigenetic regulation at bidirectional repeat loci contributes to SCA7 pathology.
- This finding highlights the importance of noncoding RNAs in neurodegenerative disease mechanisms.
Related Concept Videos
Regulation of Expression at Multiple Steps
Master Transcription Regulators
Master Transcription Regulators
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...